investorscraft@gmail.com

Intrinsic ValueDoximity, Inc. (DOCS)

Previous Close$71.03
Intrinsic Value
Upside potential
Previous Close
$71.03

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2025 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Doximity, Inc. operates a leading digital platform for medical professionals, offering a suite of tools designed to streamline communication, collaboration, and workflow efficiency in the healthcare sector. The company generates revenue primarily through subscription-based services, advertising, and premium offerings tailored to physicians, nurses, and other healthcare providers. Its platform serves as a critical hub for professional networking, telehealth solutions, and clinical decision support, positioning Doximity as a key enabler of digital transformation in healthcare. The company has established a strong market position by leveraging its extensive network of verified medical professionals, which enhances engagement and retention. Unlike general social networks, Doximity’s focus on healthcare-specific needs—such as secure messaging, e-faxing, and referral management—creates high switching costs and deepens user reliance. This specialization allows the company to command premium pricing and maintain a competitive moat against broader tech entrants. Doximity’s growth is further supported by secular trends like telehealth adoption and regulatory tailwinds favoring digital health solutions.

Revenue Profitability And Efficiency

Doximity reported revenue of $570.4 million for FY 2025, with net income of $223.2 million, reflecting a robust net margin of approximately 39%. The company’s operating cash flow of $273.3 million underscores strong cash generation capabilities, while negligible capital expenditures highlight capital-light operations. These metrics indicate high operational efficiency and scalability inherent in its software-driven model.

Earnings Power And Capital Efficiency

The company’s diluted EPS of $1.11 demonstrates its ability to translate top-line growth into shareholder returns. With no significant capital expenditures, Doximity’s free cash flow closely aligns with operating cash flow, emphasizing capital efficiency. This positions the company to reinvest in product development or pursue strategic acquisitions without straining its balance sheet.

Balance Sheet And Financial Health

Doximity maintains a solid financial position, with $209.6 million in cash and equivalents against minimal total debt of $12.4 million. The negligible leverage and strong liquidity provide flexibility to navigate market fluctuations or fund growth initiatives. The absence of dividends suggests a focus on retaining earnings for reinvestment or share repurchases.

Growth Trends And Dividend Policy

Doximity’s revenue and profitability trends reflect sustained demand for its platform, though specific growth rates are undisclosed. The company does not currently pay dividends, opting instead to prioritize organic growth and potential M&A. Its capital-light model and high margins support future scalability without requiring significant external financing.

Valuation And Market Expectations

The market likely values Doximity on its premium profitability metrics and growth potential in digital health. Its P/E ratio and other valuation multiples would hinge on expectations for sustained adoption of telehealth and workflow tools, though comparable benchmarks are unavailable without further data.

Strategic Advantages And Outlook

Doximity’s network effects, healthcare specialization, and scalable platform provide durable competitive advantages. The outlook remains positive, driven by industry digitization tailwinds, though regulatory changes or competition could pose risks. The company’s financial health positions it well to capitalize on emerging opportunities in the healthcare technology space.

Sources

Company filings (CIK: 0001516513), estimated FY 2025 data

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2026202720282029203020312032203320342035203620372038203920402041204220432044204520462047204820492050

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount